Congenital Disorders of N-Glycosylation Including Diseases Associated With O- as Well as N-Glycosylation Defects

The congenital disorders of N-glycosylation (CDG), a steadily increasing group of multi-systemic disorders, have severe clinical implications in infancy and early childhood. The various inborn errors responsible adversely affect N-glycosylation of lysosomal proteins because of either failing assembly of lipid-linked (LL) oligosaccharides (OS) in the endoplasmic reticulum, CDG Type I, or faulty processing of the asparagines (N)-linked OS in the ER and in the Golgi, CDG Type II. The overlap of phenotypes precludes specific clinical delineation. Isoelectric focusing (IEF) of plasma transferrin remains a valuable, albeit imperfect, screening tool. IEF of plasma ApoC-III protein, introduced O-glycosylation defects that delineated some new CDGs due to mutations of both N- and O-glycosylation. Only CDG-Ib is amenable to treatment with free mannose supplementation. Hence, early specific diagnosis of any one entity is crucial for genetic counseling and elective preventive measures.

[1]  R. Wevers,et al.  Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. , 2003, Clinical chemistry.

[2]  G. Matthijs,et al.  Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia). , 1999, Molecular genetics and metabolism.

[3]  Gert Matthijs,et al.  Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic , 2000, Human Genetics.

[4]  H. Freeze,et al.  Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie) , 2000, The Journal of clinical investigation.

[5]  J. Jaeken,et al.  Congenital disorders of glycosylation (CDG): It's all in it! , 2003, Journal of Inherited Metabolic Disease.

[6]  R. Rossi,et al.  Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of mannosyltransferase I. , 2004, American journal of human genetics.

[7]  F. Skovby,et al.  Early manifestations of the carbohydrate-deficient glycoprotein syndrome. , 1993, The Journal of pediatrics.

[8]  P. de Cock,et al.  Carbohydrate-deficient glycoprotein syndrome type II , 1993, Journal of Inherited Metabolic Disease.

[9]  H. Freeze,et al.  Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathology. , 2005, The Journal of pediatrics.

[10]  I. Kirsch,et al.  The human galactosyltransferase gene is on chromosome 9 at band p13 , 1986, Somatic cell and molecular genetics.

[11]  E. Berger,et al.  ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg. , 2002, Human molecular genetics.

[12]  J. Saudubray,et al.  Protein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac St-Jean, Quebec is a congenital disorder of glycosylation type Ib , 2002, Journal of medical genetics.

[13]  H. Freeze,et al.  Deficiency of UDP‐GlcNAc:Dolichol Phosphate N‐Acetylglucosamine‐1 Phosphate Transferase (DPAGT1) Causes a Novel Congenital Disorder of Glycosylation Type Ij , 2003, Human mutation.

[14]  Amos Etzioni,et al.  Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency , 2001, Nature Genetics.

[15]  E. Berger,et al.  Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. , 2000, The Journal of clinical investigation.

[16]  J. Denecke,et al.  Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies , 2003, European Journal of Pediatrics.

[17]  R. Oriol,et al.  Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. , 2005, Blood.

[18]  G. Matthijs,et al.  Evidence for genetic heterogeneity in the carbohydrate-deficient glycoprotein syndrome type I (CDG1). , 1996, Genomics.

[19]  H. Freeze,et al.  A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If). , 2001, The Journal of clinical investigation.

[20]  R. Gershoni-baruch,et al.  Rambam-Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype. , 1992, American journal of medical genetics.

[21]  M. Nöthen,et al.  Localization of the human glucosidase I gene to chromosome 2p12-p13 by fluorescence in situ hybridization and PCR analysis of somatic cell hybrids. , 1996, Genomics.

[22]  T. Hennet,et al.  Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency) , 2004, Journal of Medical Genetics.

[23]  L. Mengle-Gaw.  Genomic structure and expression of human ?-1,4-galactosyltransferase , 1991 .

[24]  A. Helenius,et al.  Roles of N-linked glycans in the endoplasmic reticulum. , 2004, Annual review of biochemistry.

[25]  G. Matthijs,et al.  Annals of the New York Academy of Sciences Congenital Disorders of Glycosylation , 2022 .

[26]  E. Green,et al.  Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation. , 2002, American journal of medical genetics.

[27]  H. Freeze,et al.  Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism☆☆☆ , 1999, The Journal of Pediatrics.

[28]  E. Bieberich,et al.  Cloning and expression of glucosidase I from human hippocampus. , 1995, European journal of biochemistry.

[29]  E. Pardon,et al.  Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13 in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome) , 1997, Nature Genetics.

[30]  J. Jaeken,et al.  The carbohydrate-deficient glycoprotein syndrome. A new inherited multisystemic disease with severe nervous system involvement. , 1991, Acta paediatrica Scandinavica. Supplement.

[31]  K. von Figura,et al.  Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. , 2004, American journal of human genetics.

[32]  E. Bertini,et al.  Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. , 1998, American journal of human genetics.

[33]  O. Bohorov,et al.  Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder , 2004, Nature Medicine.

[34]  G. Turcatti,et al.  Purification, cDNA cloning and heterologous expression of human phosphomannose isomerase. , 1994, European journal of biochemistry.

[35]  F. Hanefeld,et al.  Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  F. Hanefeld,et al.  Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406. , 1994, Human molecular genetics.

[37]  G. Raymond,et al.  MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. , 2001, The Journal of clinical investigation.

[38]  R. Wevers,et al.  Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups. , 2005, Glycobiology.

[39]  M. Hoylaerts,et al.  Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications , 2001, Journal of Inherited Metabolic Disease.

[40]  E. Schaftingen,et al.  Defects of N-glycan synthesis , 2001 .

[41]  T. Hennet,et al.  CDG‐IL: An infant with a novel mutation in the ALG9 gene and additional phenotypic features , 2005, American journal of medical genetics. Part A.

[42]  E. Schaftingen,et al.  Phosphomannomutase deficiency is a cause of carbohydrate‐deficient glycoprotein syndrome type I , 1995, FEBS letters.

[43]  W. Gahl,et al.  Carbohydrate-deficient glycoprotein syndrome. , 1997, Advances in pediatrics.

[44]  M. Krieger,et al.  The COG and COPI complexes interact to control the abundance of GEARs, a subset of Golgi integral membrane proteins. , 2004, Molecular biology of the cell.

[45]  E. Berger,et al.  A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  W. Chung,et al.  Congenital disorder of glycosylation id presenting with hyperinsulinemic hypoglycemia and islet cell hyperplasia. , 2005, The Journal of clinical endocrinology and metabolism.

[47]  D. Tiemeier,et al.  Genomic structure and expression of human beta-1,4-galactosyltransferase. , 1991, Biochemical and biophysical research communications.

[48]  J. Jaeken,et al.  Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. , 1996, American journal of human genetics.

[49]  E. Schaftingen,et al.  Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. , 1998, American journal of human genetics.

[50]  P. Clayton,et al.  Carbohydrate-Deficient Glycoprotein Syndromes: Inborn Errors of Protein Glycosylation , 1999, Annals of clinical biochemistry.

[51]  T. Marquardt,et al.  Congenital disorder of glycosylation type 1a in a macrosomic 16-month-old boy with an atypical phenotype and homozygosity of the N216I mutation , 2003, European Journal of Pediatrics.

[52]  J. Denecke,et al.  Congenital Disorder of Glycosylation Type Id: Clinical Phenotype, Molecular Analysis, Prenatal Diagnosis, and Glycosylation of Fetal Proteins , 2005, Pediatric Research.

[53]  N. Callewaert,et al.  Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Saudubray,et al.  Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. , 1999, The Journal of pediatrics.

[55]  M. Durán,et al.  A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. , 1998, Biochemical and biophysical research communications.

[56]  V. Ramaekers,et al.  Carbohydrate-deficient glycoprotein syndrome type II , 1993, Journal of Inherited Metabolic Disease.

[57]  K. von Figura,et al.  A New Type of Congenital Disorders of Glycosylation (CDG-Ii) Provides New Insights into the Early Steps of Dolichol-linked Oligosaccharide Biosynthesis* , 2003, Journal of Biological Chemistry.

[58]  E. Berger,et al.  Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL. , 2004, American journal of human genetics.

[59]  A Etzioni,et al.  Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. , 1992, The New England journal of medicine.

[60]  B. Hagberg,et al.  Carbohydrate-deficient glycoprotein syndromes: peculiar group of new disorders. , 1993, Pediatric neurology.

[61]  K. Takeshita,et al.  Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency. , 1993, The Journal of biological chemistry.

[62]  M. Krieger,et al.  Retrograde transport on the COG railway. , 2006, Trends in cell biology.

[63]  F. Hanefeld,et al.  Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig. , 2002, The Biochemical journal.

[64]  G. Hoffmann,et al.  Congenital Disorder of Glycosylation IId (CDG-IId) - A New Entity: Clinical Presentation with Dandy-Walker Malformation and Myopathy , 2002, Neuropediatrics.

[65]  J. Denecke,et al.  An activated 5′ cryptic splice site in the human ALG3 gene generates a premature termination codon insensitive to nonsense‐mediated mRNA decay in a new case of congenital disorder of glycosylation type Id (CDG‐Id) , 2004, Human mutation.

[66]  Andrés Hidalgo,et al.  Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. , 2003, Blood.

[67]  H. Freeze,et al.  Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. , 1999, The Journal of pediatrics.

[68]  R. Reithmeier,et al.  Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS). , 1995, European journal of biochemistry.

[69]  Toshihiko Oka,et al.  Characterization of a mammalian Golgi-localized protein complex, COG, that is required for normal Golgi morphology and function , 2002, The Journal of cell biology.

[70]  H. Freeze,et al.  Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG‐Ib) , 2000, Human mutation.

[71]  H. Carchon,et al.  [Carbohydrate-deficient glycoprotein syndrome]. , 1996, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[72]  S. Munro,et al.  Vesicle tethering complexes in membrane traffic. , 2002, Journal of cell science.

[73]  G. Dacremont,et al.  A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. , 2000, American journal of human genetics.

[74]  A. Munnich,et al.  Congenital disorders of glycosylation IIa cause growth retardation, mental retardation, and facial dysmorphism , 2000, Journal of medical genetics.

[75]  M. Tonetti,et al.  Fucose supplementation in leukocyte adhesion deficiency type II. , 2000, Blood.

[76]  N. Galeano,et al.  Secretory diarrhea with protein-losing enteropathy, enterocolitis cystica superficialis, intestinal lymphangiectasia, and congenital hepatic fibrosis: a new syndrome. , 1986, The Journal of pediatrics.

[77]  C. Rodeck,et al.  Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus , 1993, The Lancet.

[78]  P. Codogno,et al.  Congenital Disorders of Glycosylation Type Ig Is Defined by a Deficiency in Dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl Mannosyltransferase* , 2002, The Journal of Biological Chemistry.

[79]  E. Berger,et al.  Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. , 2002, The Journal of clinical investigation.

[80]  P. Codogno,et al.  A Deficiency in Dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl α3-Glucosyltransferase Defines a New Subtype of Congenital Disorders of Glycosylation* , 2003, The Journal of Biological Chemistry.

[81]  M. Fukuda,et al.  Identification of the full-length coding sequence for human galactosyltransferase (β-N-acetylglucosaminide: β1,4-galactosyltransferase) , 1988 .

[82]  M. Aebi,et al.  The dolichol pathway of N-linked glycosylation. , 1999, Biochimica et biophysica acta.

[83]  G. Matthijs,et al.  CDG-Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter). , 2005, European journal of medical genetics.

[84]  H. Carchon,et al.  The carbohydrate-deficient glycoprotein syndromes: An overview , 1993, Journal of Inherited Metabolic Disease.

[85]  Y. Wada,et al.  Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. , 1992, Biochemical and biophysical research communications.

[86]  G. Matthijs,et al.  Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families , 1998, European Journal of Human Genetics.

[87]  J. Jaeken,et al.  What's new in congenital disorders of glycosylation? , 2000, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[88]  H. Freeze,et al.  Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig. , 2005, Molecular genetics and metabolism.

[89]  T. Hennet,et al.  Congenital disorders of glycosylation: genetic model systems lead the way. , 2001, Trends in cell biology.

[90]  M. Fukuda,et al.  Identification of the full-length coding sequence for human galactosyltransferase (beta-N-acetylglucosaminide: beta 1,4-galactosyltransferase). , 1988, Biochemical and biophysical research communications.

[91]  E. Berger,et al.  A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. , 1998, The Journal of clinical investigation.

[92]  T. Marquardt.  A COG in the sugar machine , 2004, Nature Medicine.

[93]  K. Yamashita.  Carbohydrate-deficient glycoprotein syndrome type I. , 1996 .

[94]  U. Stephani,et al.  Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl‐P‐Man:Man5 GlcNAc2‐PP‐dolichyl mannosyltransferase , 1999, The EMBO journal.

[95]  K. von Figura,et al.  A New Type of Carbohydrate-deficient Glycoprotein Syndrome Due to a Decreased Import of GDP-fucose into the Golgi* , 1999, The Journal of Biological Chemistry.

[96]  Rita Gerardy-Schahn,et al.  The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter , 2001, Nature Genetics.

[97]  U. Stephani,et al.  Carbohydrate-Deficient Glycoprotein Syndrome - A Fourth Subtype , 1995, Neuropediatrics.